1048 related articles for article (PubMed ID: 24821925)
1. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Broer SL; Broekmans FJ; Laven JS; Fauser BC
Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
[TBL] [Abstract][Full Text] [Related]
2. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the utility of anti-Müllerian hormone in female infertility.
Grynnerup AG; Lindhard A; Sørensen S
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):162-7. PubMed ID: 24722366
[TBL] [Abstract][Full Text] [Related]
4. [Level of AMH as a predictor of the result of ovarian stimulation].
Vrublovský P
Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
[TBL] [Abstract][Full Text] [Related]
5. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
6. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
[TBL] [Abstract][Full Text] [Related]
7. The role of anti-Müllerian hormone in female fertility and infertility - an overview.
Grynnerup AG; Lindhard A; Sørensen S
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone as a predictor of reproductive potential.
Hawkins Bressler L; Steiner A
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
[TBL] [Abstract][Full Text] [Related]
9. Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?
Anderson RA; Nelson SM; Wallace WH
Maturitas; 2012 Jan; 71(1):28-33. PubMed ID: 22119275
[TBL] [Abstract][Full Text] [Related]
10. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
Chan C; Liu K
J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
[TBL] [Abstract][Full Text] [Related]
12. An assessment of anti-Müllerian hormone in predicting mating outcomes in female hamsters that have undergone natural and chemically-accelerated reproductive aging.
Roosa KA; Zysling DA; Place NJ
Gen Comp Endocrinol; 2015 Apr; 214():56-61. PubMed ID: 25801548
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
14. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
16. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
Alebic MŠ; Stojanovic N; Dewailly D
Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.
Tran ND; Cedars MI; Rosen MP
J Clin Endocrinol Metab; 2011 Dec; 96(12):3609-14. PubMed ID: 21937624
[TBL] [Abstract][Full Text] [Related]
19. Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness and indications of AMH assay in women].
Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
